Drug makers urged to go global

Domestic pharmaceutical firms need to upgrade their global standard policy in the era of free trade agreement instead of heated argument over wholesaler margin, according to experts.

They argue that the wholesaling industry should endeavor to further upgrade their corporate governance to wipe out the recurrence of illegal rebates.

There is mounting concerns that if some domestic pharmaceu...